# CAPLYTA

NDC: 72060-110
Generic name: lumateperone
Labeler / Manufacturer: Intra-Cellular Therapies, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20220809

FDA application: NDA209500

## Active ingredients

- LUMATEPERONE: 10.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72060-110"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72060-110
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db730b06-6351-47fd-8183-e61e61bbead5